Pasumai Pharmacies India Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
as on 11-12-2024
- Paid Up Capital ₹ 1.60 M
as on 11-12-2024
- Company Age 17 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 3.80 Cr
as on 11-12-2024
- Revenue 49.11%
(FY 2022)
- Profit -18.92%
(FY 2022)
- Ebitda -297.79%
(FY 2022)
- Net Worth 18.76%
(FY 2022)
- Total Assets 83.75%
(FY 2022)
About Pasumai Pharmacies India
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 1.60 M.
The company has closed loans amounting to ₹3.80 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Samundeeswari, Karuppaiah Pravinbabu, and Karuppiah Arun serve as directors at the Company.
- CIN/LLPIN
U51397TZ2007PTC013631
- Company No.
013631
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 Apr 2007
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Coimbatore
Industry
Company Details
- Location
Coimbatore, Tamil Nadu, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Pasumai Pharmacies India Private Limited offer?
Pasumai Pharmacies India Private Limited offers a wide range of products and services, including Medicines, Eye Care Medicines, Me Pharm, Etodolac, Gastrointestinal Drugs, Rabeprazole, Ind Chem, 2 Chloroethylamine Hydrochloride, Eye Ointments, Animal Health Products.
Who are the key members and board of directors at Pasumai Pharmacies India?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Samundeeswari  | Managing Director | 30-Aug-2008 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Karuppiah Arun | Director | 30-Aug-2023 | Current |
| Karuppaiah Pravinbabu | Director | 30-Aug-2023 | Current |
Financial Performance of Pasumai Pharmacies India.
Pasumai Pharmacies India Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 49.11% increase. The company also saw a substantial fall in profitability, with a 18.92% decrease in profit. The company's net worth Soared by an impressive increase of 18.76%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Pasumai Pharmacies India?
In 2022, Pasumai Pharmacies India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 28 Jun 2017 | ₹2.50 M | Satisfied |
Axis Bank Limited Creation Date: 13 Jul 2013 | ₹2.60 Cr | Satisfied |
Hdfc Bank Limited Creation Date: 18 Apr 2013 | ₹1.00 M | Satisfied |
How Many Employees Work at Pasumai Pharmacies India?
Pasumai Pharmacies India has a workforce of 67 employees as of Apr 01, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Pasumai Pharmacies India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pasumai Pharmacies India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
